Agnuside T3868
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3, 66.8, and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5, 25, and 100 _M, respectively.
CAS nr:
11027-63-7
Purity:
98%
Molecular Weight:
466,44
SMILES:
OC[C@H]1O[C@@H](O[C@@H]2OC=C[C@H]3[C@H](O)C=C(COC(=O)c4ccc(O)cc4)[C@@H]23)[C@H](O)[C@@H](O)[C@@H]1O
Formula:
C22H26O11
Pathway:
GPCR/G Protein,Immunology/Inflammation,Neuroscience,Membrane transporter/Ion channel,Neuroscience,Immunology/Inflammation
Target:
Prostaglandin Receptor,Prostaglandin Receptor,P-gp,P-gp,COX,COX
